کد مقاله کد نشریه سال انتشار مقاله انگلیسی نسخه تمام متن
1918481 1047955 2009 5 صفحه PDF دانلود رایگان
عنوان انگلیسی مقاله ISI
Progestogen use in women approaching the menopause and breast cancer risk
موضوعات مرتبط
علوم زیستی و بیوفناوری بیوشیمی، ژنتیک و زیست شناسی مولکولی سالمندی
پیش نمایش صفحه اول مقاله
Progestogen use in women approaching the menopause and breast cancer risk
چکیده انگلیسی
The most important and widely accepted indications to the use of progestogens in the years preceding the menopause are anovulatory menstrual disorders, for which a limited period of treatment is generally sufficient. Awaiting for further data, when using progestogens for longer periods to treat other problems (endometriosis, cyclical mastalgia, etc.), the possibility of increased breast cancer risk and clinical benefits have to be weighed. Anyway, as micronized progesterone and dydrogesterone, at least when they were used in postmenopausal HT, seem to have, according to a large observational study, a safer risk profile on the breast, the preferential use of these preparations could be suggested.
ناشر
Database: Elsevier - ScienceDirect (ساینس دایرکت)
Journal: Maturitas - Volume 62, Issue 4, 20 April 2009, Pages 338-342
نویسندگان
, , , ,